Galmed Pharmaceuticals
GLMD
#10337
Rank
A$3.85 M
Marketcap
$2.33
Share price
-8.80%
Change (1 day)
-60.00%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$10.10

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$10.73. In 2022 the company made an earnings per share (EPS) of -$16.96 an increase over its 2021 EPS that were of -$31.77.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$10.10-40.46%
2022-$16.96-46.62%
2021-$31.77-2.22%
2020-$32.4939.18%
2019-$23.3570.18%
2018-$13.72-41.84%
2017-$23.59-34.23%
2016-$35.8656.84%
2015-$22.879.2%
2014-$20.94-53.43%
2013-$44.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.07-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.45-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.20-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.79-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA